DCTH Short Information, Delcath Systems Inc

Twenty Trading Day Totals
Total Shorted Volume	215,788
Total Actual Volume	1,080,096

Averages
Average Short Volume	10,789
Average Short Percentage	28.00%

Is there a DCTH Short Squeeze or Breakout about to happen?

See the DCTH Short Analysis for free Sign up or Login

Stock Date	Open Price	Close Price	High	Low	Total Volume	Short Volume	Short Percentage
2020-04-28	12.75	12.75	12.75	12.75	312	213	68.2692
2020-04-13	13	13	13	13	386	125	32.3834
2020-04-06	12.19	12.19	12.19	12.19	448	144	32.1429
2020-04-03	11.51	12	12	11.51	1,498	200	13.3511
2020-03-31	10.5	10	10.7	10	1,555	800	51.4469
2019-10-15	0.091	0.091	0.092	0.091	17,289	402	5.3436
2019-10-11	0.11	0.091	0.11	0.08	355,136	2,162	0.5841
2019-10-10	0.10	0.105	0.11	0.10	26,981	12,751	47.2592
2019-10-09	0.093	0.10	0.10	0.0901	83,289	55,459	66.5862
2019-10-08	0.0999	0.10	0.10	0.0911	7,771	1,522	19.5856
2019-10-07	0.10	0.10	0.10	0.086	68,220	23,750	34.8138
2019-10-04	0.10	0.0956	0.10	0.09555	60,949	20,200	33.1425
2019-10-03	0.1095	0.09605	0.1095	0.091	29,036	6,475	22.2999
2019-10-02	0.09105	0.1095	0.1099	0.091	54,230	10,723	19.7732
2019-10-01	0.091	0.1099	0.1099	0.091	27,248	64	0.2349
2019-09-30	0.091	0.10	0.1084	0.091	67,264	1,900	2.8247
2019-09-27	0.09634	0.11	0.11	0.09634	33,455	10,000	29.8909
2019-09-26	0.0921	0.0999	0.101	0.092	113,894	41,200	36.1740
2019-09-17	0.0911	0.1018	0.11	0.0911	47,060	11,598	24.6451
2019-09-16	0.0911	0.11	0.11	0.0911	84,075	16,100	19.1496

Stock Information

Delcath Systems Inc Company Name:

DCTH Stock Symbol:

OTC Market:

Get DCTH Alerts

News, Short Squeeze, Breakout and More Instantly...

DCTH - Delcath Systems Reports First Quarter 2022 Results and Provides Business Update

NEW YORK , May 10, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the first quarter ended March 31, 2022. ...
DCTH - Delcath Announces Poster Presentation at the 2022 ASCO Annual Meeting

NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced the acceptance of a poster presentation at the upcoming American Society of Clini...
DCTH - Delcath Systems to Host First Quarter 2022 Results

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on May 10, 2022, at 8:30 AM Eastern Time to discuss r...